Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02570451 · ClinicalTrials.gov registry record
Preoperative Cognitive Screening of Surgical Patients 65 Years of Age or Older
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 711
- Enrollment target
NCT02570451: Completed study, sponsored by Brigham and Women's Hospital.
NCT02570451 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 711 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02570451 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 711 participants
- Enrollment target
Study Summary
The overall objectives of this study are to improve outcomes of surgical patients 65 years of age or older through risk stratification based on preoperative screening of cognition / mental function. Aim 1 is to determine the prevalence of cognitive impairment among patients 65 years of age or older presenting for elective joint replacement surgery by structured cognitive screening versus standard practice. Aim 2 is to ascertain whether preoperative cognitive impairment in patients 65 years of age or older undergoing elective joint replacement surgery is an independent predictor of adverse postoperative events and/or mortality. Aim 3 is to implement routine structured preoperative cognitive screening of patients 65 years of age or older undergoing elective surgical procedures in a busy preoperative clinic.
Primary Outcome
On the day the patient is discharged from the hospital, the discharge location (home vs. other than home) will be recorded
Interventions
- OTHER Mini Cog
- OTHER Patient Survey
- OTHER Independent Activities of Daily Living Score Sheet
- OTHER Activities of Daily Living Score Sheet
- OTHER Geriatric Depression Scale Short Form
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 711 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-08 |
What the finished NCT02570451 record still lists
NCT02570451 is an observational study that tracks outcomes without assigning an intervention. The registered 711 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Mini Cog is the first listed.
NCT02570451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02570451 about?
NCT02570451 is a clinical study titled "Preoperative Cognitive Screening of Surgical Patients 65 Years of Age or Older". The overall objectives of this study are to improve outcomes of surgical patients 65 years of age or older through risk stratification based on preoperative screening of cognition / mental function. Aim 1 is to determine the prevalence of cognitive impairment among patients 65 years of age or older ...
What is the current status of trial NCT02570451?
This trial is currently completed. The enrollment target is 711 participants. The study started on 2014-09. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02570451?
The interventions under investigation include: Mini Cog (OTHER), Patient Survey (OTHER), Independent Activities of Daily Living Score Sheet (OTHER), Activities of Daily Living Score Sheet (OTHER), Geriatric Depression Scale Short Form (OTHER).
Who is sponsoring clinical trial NCT02570451?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia